Riskpilot← Back to searchSign inGet full accessEUROGEN ApS
APSActiveCVR 33387679Østbanegade 123Support activities for animal production · NACE 0162Est. 20111 employees
Revenue 2024
DKK -60K
+43% vs 2023
EBITDA margin
100.0%
-43% vs 2023
Equity ratio
23.0%
Financial strength
Net profit 2024
DKK -3,7M
-221% vs 2023
| Revenue | DKK -60K | +43% |
| EBITDA | DKK -60K | -43% |
| Net profit | DKK -3,7M | -221% |
| Total assets | DKK 25,4M | -12% |
| Equity | DKK 5,9M | -39% |
| Employees | 1 | — |
Legal name
EUROGEN ApS
CVR number
33387679
Legal form
Anpartsselskab
NACE code
0162 · Support activities for animal production
Founded
1. januar 2011
Share capital
DKK 80.000
Employees
1 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør
Company purpose
Selskabets formål er at drive virksomhed i form af handel med svin og dermed beslægtet virksomhed, herunder bl.a., men ikke begrænset til levende svin, embryoner, sæd, tjenesteydelser m.m.
Address
Østbanegade 123
Email
j.bondarenko@otradagroup.ru
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 54 | -799 | 958 | 0 | 0 | -50 | -99 | -105 | -82 | -66 | -74 | -42 | -60 |
| Staff expenses | -913 | -443 | -791 | -1 | -0 | -4 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -859 | -1.242 | -181 | -120 | 76 | -54 | -99 | -105 | -82 | -66 | -74 | -42 | -60 |
| Depreciation & amort. | -0 | -0 | -0 | 16 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -859 | -1.242 | -181 | -136 | 76 | -54 | -99 | -105 | -82 | -66 | -74 | -42 | -60 |
| Net financials | -101 | -265 | -377 | -771 | 995 | -1.292 | -250 | 17.128 | 1.547 | -515 | -73 | 3.107 | -3.645 |
| Profit before tax | -960 | -1.507 | -557 | -907 | 1.072 | -1.345 | -349 | 17.023 | 1.464 | -581 | -147 | 3.065 | -3.704 |
| Tax | -0 | 320 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -960 | -1.827 | -557 | -907 | 1.072 | -1.345 | -349 | 17.023 | 1.464 | -581 | -147 | 3.065 | -3.704 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.100 | 1.076 | 1.078 | 9.821 | 11.912 | 11.810 | 11.734 | 36.287 | 27.933 | 29.019 | 31.522 | 29.012 | 25.406 |
| Equity | -1.875 | -3.701 | -4.258 | -5.166 | -4.094 | -5.440 | -5.788 | 16.393 | 9.326 | 10.935 | 12.935 | 9.558 | 5.853 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3.975 | 4.777 | 5.336 | 14.986 | 16.006 | 17.250 | 17.522 | 19.894 | 18.608 | 18.083 | 18.587 | 19.454 | 19.552 |
| Total debt | 3.975 | 4.777 | 5.336 | 14.986 | 16.006 | 17.250 | 17.522 | 19.894 | 18.608 | 18.083 | 18.587 | 19.454 | 19.552 |
EBITDA margin
-5984800.0%
This company
15.8%
Market median
-37878581% vs market
20122024
Equity ratio
23.0%
This company
38.2%
Market median
-40% vs market
20122024
Return on equity
-63.3%
This company
18.4%
Market median
-444% vs market
20122024
Net profit margin
-370444100.0%
This company
8.1%
Market median
-4573384051% vs market
20122024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20122024
Debt / equity
3.34×
This company
0.62×
Market median
-439% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PE Management | Management | 2014 | — | — |
PE Management | Management | 2013 | — | — |
LT Management | Management | 2011 | — | — |
PA Management | Management | 2011 | — | — |
PK Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
PE Management | Management | 2020 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2020 | |
| Individual | 100.0% | 100.0% | 2011 | |
| Individual | 25.0% | 25.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EUROGEN ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Patrick Erwin Hoffmann | Management | 0 companies |
| Patrick Erwin Hoffmann | Management | 0 companies |
| Lars Thode Kristensen | Management | 0 companies |
| Peter Andreas Stakemann | Management | 0 companies |
| Per Knudsen | Chief Executive Officer | 0 companies |
| Patrick Erwin Hoffmann | Management | 0 companies |